MicroHarvest, a German startup developing precision-fermented alternative proteins, announced it raised EUR 1.5 million (~USD 1.7 million) from its new partner Simon Capital, bringing the total funding raised by the company to EUR 10 million (~USD 11 million).
The funds raised will be utilized to expedite commercialization efforts, including the buildout of a pilot plant in Lisbon, enabling MicroHarvest to develop prototypes and accelerate research. The company expects to launch commercially by the end of 2023 and is collaborating with a contract manufacturing partner to scale production.
This partnership, formed following the opening of MicroHarvest’s new office in Lisbon, Portugal, will leverage Simon Capital’s extensive experience in the food and beverage manufacturing space to bolster the operational knowledge of MicroHarvest’s team.
According to the company, its proprietary biomass fermentation-based technology can produce alternative protein ingredients that contain over 60% of raw protein in just 24 hours, with applications ranging from animal feed to direct use in food and pet food.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.